MDIC Graduate Milestones

Medical Device Innovation Challenge (MDIC) Graduate Milestones (2017 - Present)

2017

EndoGlow* – Tissue Reveal Technology™  (https://www.endoglow.com/)

• Non Government Funds Awarded:  $330,000 (pre-seed)
• $100,000 FuzeHub Manufacturing Grants
• Prototype and preclinical testing completed with University of Rochester
• Named by Med Tech Outlook as a Top 10 Minimally Invasive Device Solution Company
• Accepted into Cornell Center for Materials Research (CCMR)
• Accepted into Venture Creation Innovation Challenge
• Hires: CEO, COO, VP of Business Development and National Sales Manager
• Won MedTech 2021 Innovative Surgical Device Company Award
• FDA device registration complete
• Cadaver labs teaching NIR in partnership with STORZ (Albany Medical Center, University of Rochester)
• PreClinic research presented at the Society of Gynecologic Surgeons 3/2022
• Working with KOLs on clinical research studies involving complex pelvic anatomy 
• Paula J. Doyle, MD, CEO and Founder of EndoGlow selected as an American Medical Women’s Association (AMWA) Healthcare Innovation Challenge Start-up Pitch Finalist

Costello Prosthetic Warmers (https://www.costelloprosthetics.com/)

• Project accepted by Queen’s University Human Mobility Center student capstone project
• Participated in MedTech Annual Conference Pitch Event (October, 2017)
• Prototype tested in Denali mountain climb
• Licensing proposal with large manufacturer in process

2018

Avant Medical Systems – Smart backboard

• Marketed their technology with industry partners Health O Meter and Marsden

AcceliPHI (subsidiary of ANDRO) – Spinal device

• Gained patent for individuals suffering from chronic back injuries

2019

ZEPHYRx®* – Spirometry Technology/Remote Patient Monitoring (https://www.zephyrx.com/)

• Received $225,000 NHLBI SBIR grant for development and testing of breath-controlled video game for respiratory therapy
• Resident company of Johnson & Johnson Innovation, JLABS, life science incubator program
• Grew from 2 employees to 15 full-time employees
• Pivoted to bring telemedicine to lung patients during pandemic with unique software program for at-home pulmonary function testing; exploded nationally in telemedicine market
• Cystic Fibrosis Foundation purchases devices for every patient with cystic fibrosis in the US
• Over $2.5M in product sales/contracts

Halomine – Rechargeable Antimicrobial Technology (https://www.halomine.com/)

• Federal Grants Awarded:
    $   600,000       (USDA Phase II)                         $1,000,000       (NSF Phase II)
    $   175,000       (USDA Phase I)                          $2,000,000       (NYS ESD BioDefense Fund)
    $1,743,507       (NIH Phase II SBIR)                    $   100,000       (USDA Phase I SBIR)
    $     60,000       (Tech Search 3.0, US Army)        $       5,000       (Tech Search 5.0, US Army)
    $   225,000       (NSF Phase I SBIR)                     $   256,000       (NSF Phase I SBIR)
    $   250,255       (NIH Phase I SBIR)                     $   100,000       (DoD Phase I SBIR)
    $1,000,000       (USDA Phase III)                        $    325,000      (NIH Phase I)
• Non-government funding: $1,207,500; Pre-seed $2,885,000 SAFE
• Cornell University spin out company
• Funding support through Cornell Center for Materials Research (CCMR)
• Joined Plug and Play Tech Center and New Materials 2020 Accelerator Program
• Accepted into IndieBio inaugural NY program
• Awarded $1M NSF SBIR Phase II grant to advance product development
• Hired 15 employees including Dr. Xuehong Ren, one of the world’s leading authorities on synthesized monomers polymers and N-halamine chemistries as Chief Scientific Officer
• 2023: Awarded both a $1M USDA Phase III and $325K NIH Phase I funds

MedUx – User-centered Designed Products (https://www.medux-llc.com/)

• Accepted into MassChallenge Boston Accelerator
• Placed 2^nd in ACC InVenture Prize Competition

Aurie* – Reusable Intermittent Catheter System (https://livewithaurie.com/)

• Federal Grants Awarded:
  $1,776,000       (NSF)                $   500,000       (DoD)                                             
  $   100,000       (NIDILRR)         $   575,000       (NIDILRR)
• $7,250,000 Investment
• Employees Hired:  3.5
• Accepted into Harvard LaunchLab X GEO and VentureWell ASPIRE
• Won FuzeHub Commercialization Competition Awards
• Awarded FuzeHub Manufacturing Grants totaling $150,000
• Awarded Small Business Innovation Research (SBIR) grants from National Science Foundation and National Institute of Disability, Independent Living and Rehabilitation Research
• Raised $750K in funding through pre-seed round led by Lakehouse Ventures
• Received FDA Safer Technology Designation from FDA
• Awarded $575,000 Phase II NIDILRR SBIR Award to further development of automated, reusable no-touch catheter system
• CEO Souvik Paul serves as an MDIC Mentor

2020

Assistance in Motion - Powered Ride-on Device for Children with Motor Impairments
(https://www.assistanceinmotion.com/)

• Received SBIR Phase I Award of $256,000 to develop WeeBot, an infant-controlled powered ride-on device for children with motor impairments

Vita Innovations – Smart mask tracking signs of clinical deterioration (https://vitainnovations.co/)

• Won A.I. Health Hackathon, Weill Cornell Medicine
• Won 46th Annual Business Today International Conference Impact Challenge
• Accepted into Blackstone & Techstars LaunchPad Fellowship
• Collaborating with Hudson Valley Advanced Manufacturing Center and MTEC
• Awarded Cornell University Student Business of the Year (2021)
• Co-winner of the Verizon and Clinton Global Initiative 2021 Social Innovation Challenge
• Accepted into MassChallenge Early-Stage National Startup Accelerator
• Accepted and awarded grant funding from Venturewell Phase I and II E-Teams Accelerator
• Accepted and awarded grant funding from American Heart Association National Business Accelerator
• Received investment and product support from Nextfab Ventures
• Completed Phase I User-Experience Trials at an academic hospital
• Accepted into Stanford Venture Studios

2021

MindTrace - 3D Neurosurgery Brain Mapping Technology (https://mindtrace.com/)

• Accepted into AlphaLab, Healthcare and life sciences accelerator
• Working with SUNY Upstate Medical University neurosurgeon and Co-director of Upstate’s brain tumor program, Dr. Harish Babu, for clinical studies
• Completed first stage of FDA Payor Communication Task Force
• Pre-sub planned with FDA to submit via Breakthrough Device Designation
• Selected by CB Insight’s as one of 150 most promising digital health companies of 2022

Rubitection - Skin Health Assessment Technology (http://rubitection.com)

• Presented at Medica Health Tech Conference
• Selected as a finalist, Women of Color Health & Wellness Pitch
• Awarded 2022 Health Equity Flex Grant, West Coast Consortium for Technology & Innovation in Pediatrics

JelikaLite* - Precision Autism Technology (https://jelikalite.com/)

• Awarded$256,000 (NSF Phase I) for EEG-guided intelligent transcranial photobiomodulation to reduce symptoms of autism
• Received $800,000 Investment
• Accepted into Multiple Hub, Endless Frontier, M7, NYC Healthcare Program
• Won FuzeHub Commercialization Competition Award
• Participated in Syracuse University Student Engineering Capstone Program
• Completed pivotal clinical trial, presented results at Rutgers University Autism Conference
• Presented at 68^th Annual Meeting of American Academy of Child and Adolescent Psychiatry
• Presented at Symphony Conference, Brain Foundation
• Granted FDA Breakthrough Device Designation
• Completed 2 FDA Pre Submission meetings
• Completed NSF-funded open label study, replicating 2021 clinical trial results showing autistic subject significant improvements in communications and responsiveness

Oratel Diagnostics - Endometriosis Diagnostic (orateldiagnostics.com/Site/grav-admin/)

• Patent filed: PCT/EP2022/081362
• Consortium for Technology & Innovation in Pediatrics (CTIP) award of $7500
• Completed first prototype using 3-D printing to evaluate our collection of saliva samples and develop standards to monitor reader performance
• Completed data analysis on pre-clinical study with Brigham and Women’s Hospital on 181 patients
• Presented at 15th World Congress on Endometriosis, Edinburgh, Scotland re Pilot Study of Saliva-Based Assay to Diagnose Endometriosis, May 2023
• Completed Endimetrix prototype digital reader
• Sponsored study at Alfred University Material Science Department to test difference in glass surfaces
• Accepted by NSF to apply for STTR grant for 2023
• Received $10,000 CTIP Flexi Grant Award working with Dr. Monica Guisti at Ohio State University to investigate chemistry of mechanism of action for Endimetrix diagnostic
• Received $6,000 CTIP funding to assist with regulatory and marketing needs.

Dancing Eyes* - Eye Movement Disorder Technology

• SUNY Upstate Medical University faculty-founded startup company
• Completed University of Rochester regional I-Corps program
• Working with Rensselaer Polytechnic Institute (RPI), Student Engineering Capstone Program

2022

EndObetes – Endoscopic reversible treatment devices for obesity and diabetes (https://endobetes.com/)

• Angel investment, $350K
• SBIR Phase I NIH $256K, work completed
• Strategic partnership with MicroTech Endoscopy
• Completed MedTech Innovator Accelerator Program
• Coordinated FDA Pre Submission meeting
• Preclinical testing planned with SUNY Binghamton

PreTip* – Point of care EEG device for rapid screening in ED/ICU

• Upstate Medical University faculty founded company
• Phase II SBIR planning in process
• Upstate Medical University faculty-founded company

PapEasy* – cervical self-screening technology (https://papeasy.com/)

• Coordinating with regulatory consultant for FDA submission
• NSF SBIR Phase I submission in process
• Working with Buffalo area contract manufacturer
• CNYBAC Virtual Client

SurgiVance – point of care rapid diagnosis through diagnostic imaging using advanced optics (https://surgivance.com/)

• Accepted into RPI student capstone program
• In process of hiring CEO
• FDA Pre-Submission in process/seed meeting scheduled
• Submitted Phase II NIH SBIR

3Dspine – 3d printed modeling pre-operative planning for adult spine procedures

• IP submitted through University at Buffalo
• FDA and reimbursement pathway initiated
• Planned STTR submission in 2023

*CNYBAC Clients